Hjörtur Hjartarson, Sveinn Valfells, Jón Helgi Egilsson and Gísli Kristjánsson: the four founders of Monerium (2016), a company with which Tokeny has just signed a major partnership. Photo: Monerium

Hjörtur Hjartarson, Sveinn Valfells, Jón Helgi Egilsson and Gísli Kristjánsson: the four founders of Monerium (2016), a company with which Tokeny has just signed a major partnership. Photo: Monerium

Making assets more liquid via security tokens is one thing. Enabling investors to take advantage of them without having to go through exchanges is another. The partnership Tokeny has just announced with Icelandic fintech Monerium is a major development.

Why should you have to go and change euros into a crypto-currency on an exchange, then that currency into security tokens, and then the other way around when you resell those assets? Why, when the whole transaction could be hosted on the same platform, the Tokeny BillBoard?

There is no reason anymore: lower fees, fewer delays and less friction, the partnership Tokeny has announced with Icelandic fintech Monerium solves this triple problem in one go.

The fintech, born and regulated in Iceland, allows users to make transfers directly from their Iban account to the Monerium account, and thus to use this e-money to carry out their transactions on blockchains.

"Tokeny is pioneering peer-to-peer markets for digital securities and helping to bring more liquidity to private markets. Having money and securities on the same ledger allows for delivery against payment in real time, at a lower cost and with lower execution risk than in current systems," commented Monerium CEO Sveinn Valfells.

"Monerium's easy-to-use e-money solution brings accessibility to non-crypto investors while Billboard provides issuers with a secondary market solution to improve the liquidity of their financial instrument. Issuers can now improve their value proposition to investors. The more investors that join the ecosystem, the more they will benefit from positive network effects," adds Tokeny's CEO, Luc Falempin.